Immunofluorescence analysis showed that RyR1 and SERCA2 had a similar diffuse localization in control myotubes (Figure 4A), while in DM1 myotubes RyR1 expression was substantially decreased, and showed an irregular, clustered pattern of distribution (Figure 4A). The gene discussed is ATP2A2; the disease is myotonic dystrophy type 1.